Viridian Therapeutics Inc...

NASDAQ: VRDN · Real-Time Price · USD
18.10
-0.44 (-2.37%)
At close: Aug 18, 2025, 3:59 PM
18.11
0.06%
After-hours: Aug 18, 2025, 05:26 PM EDT

Viridian Therapeutics Revenue

Viridian Therapeutics reported an annual revenue of $302K, reflecting a -3.82% growth. For the quarter ending June 30, 2025, Viridian Therapeutics generated $75K in revenue.
Revenue (ttm)
302K
Revenue Growth
-3.82%
Price / Sales Ratio
4309.19
Revenue / Employee
2.11K
Employees
143
Market Cap
1.48B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 302K -3.82%
Dec 31, 2023 314K -82.28%
Dec 31, 2022 1.77M -40.20%
Dec 31, 2021 2.96M +182.19%
Dec 31, 2020 1.05M -76.46%
Dec 31, 2019 4.46M -46.80%
Dec 31, 2018 8.39M +109.49%
Dec 31, 2017 4M +19.96%
Dec 31, 2016 3.34M +31.48%
Dec 31, 2015 2.54M -41.25%
Dec 31, 2014 4.32M +0.08%
Dec 31, 2013 4.32M -2.03%
Dec 31, 2012 4.41M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.